The following data are based on findings in studies performed with sitagliptin or metformin individually
Designed for qualified researchers, this dual-peptide formulation offers a convenient combination of two widely studied research compounds in one precisely measured product
doi: 10.1016/j.gtc.2019.05.001
Patients who get early CLT involvement and early compression have substantially better lifetime trajectories than patients who present at Stage II
They help influence communication between cells and may support processes such as recovery, metabolism, inflammation balance, immune function, hormone signaling, skin health, and cognitive function
Skin biopsies and clinical photography were evaluated at weeks 4, 8, and 12